Impaired thrombin-induced platelet activation and thrombus formation in mice lacking the Ca(2+)-dependent tyrosine kinase Pyk2.
暂无分享,去创建一个
M. Falasca | M. Okigaki | A. Consonni | P. Gresele | S. Momi | B. Oliviero | C. Balduini | M. Torti | G. Guidetti | I. Canobbio | L. Cipolla
[1] E. Ongini,et al. Nitric oxide enhances the anti-inflammatory and anti-atherogenic activity of atorvastatin in a mouse model of accelerated atherosclerosis. , 2012, Cardiovascular research.
[2] E. Hirsch,et al. Role and regulation of phosphatidylinositol 3-kinase β in platelet integrin α2β1 signaling. , 2012, Blood.
[3] Koji Ikeda,et al. Early Inflammatory Reactions in Atherosclerosis Are Induced by Proline-Rich Tyrosine Kinase/Reactive Oxygen Species–Mediated Release of Tumor Necrosis Factor-&agr; and Subsequent Activation of the p21Cip1/Ets-1/p300 System , 2011, Arteriosclerosis, thrombosis, and vascular biology.
[4] Michael D Schaller,et al. Cellular functions of FAK kinases: insight into molecular mechanisms and novel functions , 2010, Journal of Cell Science.
[5] C. Lipinski,et al. Targeting Pyk2 for therapeutic intervention , 2010, Expert opinion on therapeutic targets.
[6] R. Ganju,et al. HIV-1 gp120-induced migration of dendritic cells is regulated by a novel kinase cascade involving Pyk2, p38 MAP kinase, and LSP1. , 2009, Blood.
[7] C. Libert,et al. Loss of matrix metalloproteinase 2 in platelets reduces arterial thrombosis in vivo , 2009, The Journal of experimental medicine.
[8] P. Gresele,et al. Potentiation and priming of platelet activation: a potential target for antiplatelet therapy. , 2008, Trends in pharmacological sciences.
[9] Terukatsu Sasaki,et al. Protein-tyrosine kinase CAKβ/PYK2 is activated by binding Ca2+/calmodulin to FERM F2 α2 helix and thus forming its dimer , 2008 .
[10] F. Mancini,et al. The low-molecular-weight phosphotyrosine phosphatase is a negative regulator of FcgammaRIIA-mediated cell activation. , 2007, Blood.
[11] A. Monopoli,et al. NCX 6560, a nitric oxide-releasing derivative of atorvastatin, inhibits cholesterol biosynthesis and shows anti-inflammatory and anti-thrombotic properties. , 2007, European journal of pharmacology.
[12] H. Matsubara,et al. Central Role of Calcium-Dependent Tyrosine Kinase PYK2 in Endothelial Nitric Oxide Synthase–Mediated Angiogenic Response and Vascular Function , 2007, Circulation.
[13] G. Leoncini,et al. Activation of p38 MAPKinase/cPLA2 pathway in homocysteine‐treated platelets , 2006, Journal of thrombosis and haemostasis : JTH.
[14] P. Gresele,et al. Nitroaspirin plus clopidogrel versus aspirin plus clopidogrel against platelet thromboembolism and intimal thickening in mice , 2005, Thrombosis and Haemostasis.
[15] R. Mohanlal,et al. Effect of selective inhibition of the p38 MAP kinase pathway on platelet aggregation , 2004, Thrombosis and Haemostasis.
[16] W. Durante,et al. Role of the Pyk2–MAP Kinase–cPLA2 Signaling Pathway in Shear-Dependent Platelet Aggregation , 2004, Annals of Biomedical Engineering.
[17] Takao Shimizu,et al. Regulatory mechanism and physiological role of cytosolic phospholipase A2. , 2004, Biological & pharmaceutical bulletin.
[18] F. Sinigaglia,et al. Contribution of Protease-activated Receptors 1 and 4 and Glycoprotein Ib-IX-V in the Gi-independent Activation of Platelet Rap1B by Thrombin* , 2004, Journal of Biological Chemistry.
[19] M. Sheetz,et al. Pyk2 regulates multiple signaling events crucial for macrophage morphology and migration , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[20] F. Sinigaglia,et al. Proline-rich Tyrosine Kinase 2 and Focal Adhesion Kinase Are Involved in Different Phases of Platelet Activation by vWF , 2002, Thrombosis and Haemostasis.
[21] Y. Fu,et al. RAFTK/Pyk2 involvement in platelet activation is mediated by phosphoinositide 3‐kinase , 2001, British Journal of Haematology.
[22] T. Ohmori,et al. Involvement of Hic-5 in platelet activation: integrin alphaIIbbeta3-dependent tyrosine phosphorylation and association with proline-rich tyrosine kinase 2. , 2001, The Biochemical journal.
[23] V. Duronio,et al. Thrombin‐stimulated phosphatidylinositol 3‐kinase activity in platelets is associated with activation of PYK2 tyrosine kinase: activation of both enzymes is aggregation independent , 2000, Journal of cellular physiology.
[24] T. Ohmori,et al. Involvement of proline-rich tyrosine kinase 2 in platelet activation: tyrosine phosphorylation mostly dependent on alphaIIbbeta3 integrin and protein kinase C, translocation to the cytoskeleton and association with Shc through Grb2. , 2000, The Biochemical journal.
[25] Shin-Young Park,et al. RAFTK/Pyk2-mediated cellular signalling. , 2000, Cellular signalling.
[26] M. Gelb,et al. Stress stimuli increase calcium-induced arachidonic acid release through phosphorylation of cytosolic phospholipase A2. , 1999, The Biochemical journal.
[27] G. Tokiwa,et al. Adaptor Proteins Grb2 and Crk Couple Pyk2 with Activation of Specific Mitogen-activated Protein Kinase Cascades* , 1999, The Journal of Biological Chemistry.
[28] P. Majumder,et al. Activation of p38 Mitogen-activated Protein Kinase by PYK2/Related Adhesion Focal Tyrosine Kinase-dependent Mechanism* , 1999, The Journal of Biological Chemistry.
[29] T. Ohmori,et al. Suppression of protein kinase C is associated with inhibition of PYK2 tyrosine phosphorylation and enhancement of PYK2 interaction with Src in thrombin-activated platelets. , 1999, Thrombosis research.
[30] C. Leslie. Properties and Regulation of Cytosolic Phospholipase A2 * , 1997, The Journal of Biological Chemistry.
[31] S. Watson,et al. Phosphorylation and activation of cytosolic phospholipase A2 by 38-kDa mitogen-activated protein kinase in collagen-stimulated human platelets. , 1997, European journal of biochemistry.
[32] H. Avraham,et al. Tyrosine Phosphorylation of the Novel Protein-tyrosine Kinase RAFTK during an Early Phase of Platelet Activation by an Integrin Glycoprotein IIb-IIIa-independent Mechanism* , 1997, The Journal of Biological Chemistry.
[33] O. Mandelboim,et al. Protection from Natural Killer Cell-Mediated Lysis by HLA-G Expression on Target Cells , 1996, Science.
[34] S. Lev,et al. A role for Pyk2 and Src in linking G-protein-coupled receptors with MAP kinase activation , 1996, Nature.
[35] S. Lev,et al. Activation of Pyk2 by Stress Signals and Coupling with JNK Signaling Pathway , 1996, Science.
[36] H. Avraham,et al. Characterization of RAFTK, a novel focal adhesion kinase, and its integrin-dependent phosphorylation and activation in megakaryocytes. , 1996, Blood.
[37] Robert A. H. White,et al. Identification and Characterization of a Novel Related Adhesion Focal Tyrosine Kinase (RAFTK) from Megakaryocytes and Brain (*) , 1995, The Journal of Biological Chemistry.
[38] S. Watson,et al. Cytosolic Phospholipase A2 Is Phosphorylated in Collagen- and Thrombin-stimulated Human Platelets Independent of Protein Kinase C and Mitogen-activated Protein Kinase (*) , 1995, The Journal of Biological Chemistry.
[39] Terukatsu Sasaki,et al. Cloning and Characterization of Cell Adhesion Kinase β, a Novel Protein-tyrosine Kinase of the Focal Adhesion Kinase Subfamily (*) , 1995, The Journal of Biological Chemistry.
[40] E. Peles,et al. Protein tyrosine kinase PYK2 involved in Ca2+-induced regulation of ion channel and MAP kinase functions , 1995, Nature.
[41] Y. Kiyota,et al. Beneficial effect of CV-4151 (Isbogrel), a thromboxane A2 synthase inhibitor, in a rat middle cerebral artery thrombosis model. , 1995, Thrombosis research.
[42] M. Nakashima,et al. Arterial thrombosis model with photochemical reaction in guinea-pig and its property. , 1992, Thrombosis research.
[43] J. Bruno,et al. 3,4-Dihydroquinolin-2(1H)-ones as combined inhibitors of thromboxane A2 synthase and cAMP phosphodiesterase. , 1992, Journal of medicinal chemistry.
[44] G. Nenci,et al. Picotamide Protects Mice from Death in a Pulmonary Embolism Model by a Mechanism Independent from Thromboxane Suppression , 1990, Thrombosis and Haemostasis.
[45] E. Cronkite,et al. Morphology and enumeration of human blood platelets. , 1950, Journal of applied physiology.
[46] 松井 朗裕. Central role of calcium-dependent tyrosine kinase PYK2 in endothelial nitric oxide synthase mediated angiogenic response and vascular function , 2008 .
[47] H. Ostergaard,et al. Focal adhesion kinase-related protein tyrosine kinase Pyk2 in T-cell activation and function , 2005, Immunologic research.
[48] L. Moro,et al. Nongenomic effects of 17β-estradiol in human platelets: potentiation of thrombin-induced aggregation through estrogen receptor β and Src kinase , 2005 .
[49] L. Moro,et al. Nongenomic effects of 17beta-estradiol in human platelets: potentiation of thrombin-induced aggregation through estrogen receptor beta and Src kinase. , 2005, Blood.
[50] P. Gresele,et al. Thromboxane synthase inhibitors, thromboxane receptor antagonists and dual blockers in thrombotic disorders. , 1991, Trends in pharmacological sciences.